Tech Company Financing Transactions
Basilea Pharmaceutica Funding Round
Basilea Pharmaceutica secured a $30 million funding round on 7/29/2026. Backers included Biomedical Advanced Research and Development Authority.
Transaction Overview
Company Name
Announced On
7/29/2026
Transaction Type
Debt
Amount
$30,000,000
Round
Undisclosed
Proceeds Purpose
The additional funding will continue to advance Basilea's ongoing phase 3 program for the novel antifungal, fosmanogepix.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Hegenheimermattweg 167b
Allschwil, 4123
Switzerland
Allschwil, 4123
Switzerland
Phone
Website
Email Address
Overview
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea has about 190 employees. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands, Cresemba® for the treatment of invasive fungal infections and Zevtera® for the treatment of bacterial infections. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Veitch
Chief Financial Officer
Adesh Kaul
Chief Medical Officer
Marc Engelhardt
Chief Scientific Officer
Laurenz Kellenberger
Chief Technical Officer
Gerrit Hauck
VP - General Counsel
Damian Heller
VP - Human Resources
Ursula Eberhardt
VP - Regulatory Affairs
Peter Bielmeier
VP - Regulatory Affairs
Mark Jones
Browse more venture capital transactions:
Prev: 7/29/2026: Multibeam venture capital transaction
Next: 7/29/2026: Pangram venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs